Synlogic (SYBX) Reports Q3 Loss of $0.43, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Synlogic (SYBX) Reports Q3 Loss of $0.43, Revenues Beat

Synlogic (SYBX) Presents Data at Liver Meeting Supporting Evaluation of Synthetic Biotic for Potential Treatment of Hyperammonemia

November 12, 2018 4:25 PM EST

Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage drug discovery and development company applying synthetic biology to beneficial microbes to develop novel living medicines, today announced the presentation of data from a cross-sectional study on ammonia levels in patients with cirrhosis and healthy volunteers, and preclinical studies of its Synthetic Biotic strains in rodent models of liver failure. The presentations were made at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Disease (AASLD), which is being held in San Francisco, November 9 to 13, 2018.

Hepatic Encephalopathy is a... More